Human neuron model identifies potential therapeutic targets for Alzheimer’s disease

FHS
April 5, 2024
7:59 pm

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain-;a process that drives cognitive decline in Alzheimer’s disease and frontotemporal dementia.

FDA determines GLP-1s not linked to suicidal thoughts or actions in preliminary review

The FDA found that the use of GLP-1s to treat diabetes and obesity do not cause suicidal thoughts or actions in a preliminary review of

January 12, 2024

Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles

Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases.

April 5, 2024

New study finds link between maternal and infant sleep patterns

New mothers can expect sleep deprivation in the first few years of baby’s life. But too little sleep can take a toll on the health

July 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.